KATHERINE PANICE: Open Payments
NPI 1619321718 · OLYMPIA FIELDS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,339 in 122 payments from 19 companies in 2025. Trend: 2023 $1,604 · 2024 $1,527 · 2025 $2,339
Food & beverage: $2,339
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $378 |
| Avadel CNS Pharmaceuticals, LLC | 7 | $208 |
| Insmed, Inc. | 9 | $199 |
| GENZYME CORPORATION | 10 | $167 |
| Grifols USA, LLC | 7 | $166 |
| AstraZeneca Pharmaceuticals LP | 10 | $165 |
| Viatris Specialty LLC | 7 | $150 |
| Verona Pharma, Inc. | 9 | $148 |
| JAZZ PHARMACEUTICALS INC. | 5 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
Products named: NUCALA, LUMRYZ, DUPIXENT, Arikayce, Prolastin-C Liquid, YUPELRI, Ohtuvayre, XYWAV.
Industry payments across IL — which companies pay providers there.
